The estimated Net Worth of Patty Dumond is at least $308 mil dollars as of 27 February 2019. Patty Dumond owns over 5,000 units of Invitae Corp stock worth over $1,776 and over the last 10 years Patty sold NVTA stock worth over $306,546.
Patty has made over 23 trades of the Invitae Corp stock since 2016, according to the Form 4 filled with the SEC. Most recently Patty sold 5,000 units of NVTA stock worth $98,550 on 27 February 2019.
The largest trade Patty's ever made was selling 5,014 units of Invitae Corp stock on 15 May 2018 worth over $34,897. On average, Patty trades about 1,286 units every 35 days since 2015. As of 27 February 2019 Patty still owns at least 88,811 units of Invitae Corp stock.
You can see the complete history of Patty Dumond stock trades at the bottom of the page.
Patty's mailing address filed with the SEC is 1400 16th St, San Francisco, CA 94103, USA.
Over the last 10 years, insiders at Invitae Corp have traded over $68,349,838 worth of Invitae Corp stock and bought 2,982,686 units worth $18,086,236 . The most active insiders traders include Bros. Advisors Lp Baker Bro..., Bros. Advisors Lpbaker Feli... y James E Deerfield Mgmt L.P..... On average, Invitae Corp executives and independent directors trade stock every 14 days with the average trade being worth of $540. The most recent stock trade was executed by Robert L Nussbaum on 13 June 2023, trading 7,086 units of NVTA stock currently worth $9,779.
invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people.
Invitae Corp executives and other stock owners filed with the SEC include: